Radiation for prostate cancer that returned after surgery
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new way of delivering radiation for prostate cancer that has come back after prostate surgery. It may help control the cancer by targeting the “prostate bed” area or nearby lymph nodes where it returned.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had prostate cancer surgery before, and the cancer was adenocarcinoma
- Your cancer has signs of return on imaging in the prostate bed area or nearby pelvic lymph nodes
- Your recurrence is in the usual post-surgery radiation field area
- Your PSA blood test has been detectable at least twice, more than 30 days apart (above 0.02 ng/dL)
- No evidence of cancer spread to distant organs (no metastatic disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving a higher dose of radiation to areas where prostate cancer has returned after surgery, while giving a lower dose to healthy nearby tissue, to reduce side effects while still treating the cancer effectively.
This trial tests whether targeting the spots where cancer has returned with radiation or surgery, with or without hormone therapy, can help control prostate cancer that has come back in a few places after previous treatment.
This trial studies a targeted, high-intensity radiation approach given after prostate removal surgery when prostate cancer seems to be coming back locally. It may help control the disease in the pelvis while avoiding treatment that could cause more side effects.
This trial looks at radiation therapy given after prostate surgery (or if needed later) for prostate cancer where lymph nodes were not involved. It may help patients whose PSA rises or who need additional treatment to reduce the chance the cancer comes back.
This trial tests a precise, short-course radiation treatment (stereotactic body radiotherapy) after prostate removal surgery that adapts to your body each day to reduce side effects. It is for people whose prostate cancer has high-risk features or a rising PSA after surgery.
This study tests whether radiation therapy to the pelvis after prostate removal helps men whose cancer was found in nearby lymph nodes. The goal is to prevent cancer from coming back and improve survival.
Hear when a new Recurrent Prostate Cancer After Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.